- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05128708
Combined Medial and Caudal Approach for Right Hemicolectomy
Safety and Feasibility of the Combined Medial and Caudal Approach in Open and Laparoscopic Radical Right Hemicolectomy for Right Colon Cancer
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The incidence of colorectal cancer is increasing. Slight shift towards right colon cancer is noticed in the last 2 decades in Egypt. This can be attributed to advances in diagnostic tools and increased public health awareness as right sided colon cancer was almost presented late as most of tumors located in the capacious cecum. Hence, early diagnosis with good radical procedure offers better outcome, quality of life and survival. Many approaches for right colon resection were described. In this study we adopted the combined medial and caudal approach for right colon resection in cases of right colon cancer in both open and laparoscopic techniques.
Traditionally, approach to right colon cancer is through open exploration but this approach has more blood loss, prolonged postoperative hospital stay, sever postoperative pain and delayed recovery.
As combined medial and caudal approach is a radical procedure,the purpose of the present study was to compare between laparoscopic and open right hemicolectomy both done with combined medial and caudal approach in right colon cancer as regards technical feasibility, advantages and disadvantages of both procedures.
This was prospective randomized study and was carried out on 26 participants as number of cases with right hemicolon cancer is about 2 per month in our center. Those participants diagnosed as operable right sided colon cancer and the participants were divided into two groups:
Group I: Open combined medial and caudal right hemicolectomy included 13 participants Group II: Laparoscopic combined medial and caudal right hemicolectomy included 13 participants
All patients with inclusion criteria were subjected to preoperative assessment in the form of:
- Full history.
- Clinical evaluation.
- Laboratory investigation (Complete blood picture, liver function tests, blood sugar, blood urea, serum creatinine, prothrombin time, serum albumin and tumour marker CEA).
- Imaging (chest X-ray, US abdomen, CT abdomen and pelvis).
- Histopathology diagnosis (endoscopic biopsy, tissue diagnosis).
- Determined whether participants underwent open or laparoscopic operation is multifactorial e.g., patients desire, contraindications for laparoscopy and mass size if more than 5 cm preferred to have open surgery.
- Informed written consent taken from the patients or the legal guardian.
operative technique: both groups offered combined medial and caudal approach
- Fasting for 6 hours with no oral intake or only clear fluids intake the day before or better bowel preparation.
- After confirming the availability of blood of matching blood group, general anesthesia is inducted and prophylactic antibiotics are given.
Patient positioning:
- group I: (Open cases) The standard position for an open right hemicolectomy is supine with strapping of the ankle and wrists, such as the Trendelenburg position. The surgeon stands on the patient's left, and the first assistant stands across from the surgeon on the patient's right. The scrub nurse stands beside the surgeon. If a second assistant is needed, he or she usually stands across from the surgeon to the left of the first assistant.
- group II: laparoscopic cases: The patient should be placed in the supine position with his two legs apart and arms tucked beside the body.
The surgeon should stand between the patient's legs with the assistant standing on the patient's left and the camera operator standing on the assistant's left side, and the scrub nurse on the patient's right side.
The video monitor is placed on the patient's upper right.
- Abdominal access and trocar placement by open or closed technique using veress needle for pneumoperitoneum with an intraperitoneal pressure of 14 mmHg.
- The procedure requires 5 trocars.
- A 10 mm trocar is placed 3 cm below umbilicus for the 30° angled telescope to get an adequate view. The incision would be enlarged to extract the specimen and performing anastomosis.
- A12 mm trocar is introduced 5 cm below the telescope port for the surgeon right hand instrument.
- A 5 mm port is inserted at the McBurney's point for the surgeon's left hand instrument.
- Additional two 5 mm trocars are placed at the opposite of McBurney's point and the right subcostal position respectively for the assistant to retract and display the colon and mesocolon.
Intraoperatively, all patients will be assessed for:
- Time of the procedure.
- Amount of blood loss.
post operatively: Postoperative medications given. Monitoring of vital signs and drains. post operative assesment of pain is subjective to the participant as he gave it a score from 1 to 10. minimal pain score(1 to 3), mild (4 to 6) and sever (7 to 10). Ambulation and clear oral fluids started when intestinal sounds are audible followed by soft diet. The intraperitoneal tube drain removed when there is less than 50cc of fluid per 24h or after performing ultrasonography.
Follow up:
Participants are reviewed as outpatients weekly for 1 month or more frequent if they develop any complications between their visits.
The postoperative pathological results, number of lymph node dissection, postoperative exhaust time, postoperative abdominal drain volume and duration, postoperative short term complications, hospital stay and postoperative pathological staging will be recorded.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Zagazig, Egypt, 44519
- Zagazig University Hospitals
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosed right colon cancer with colonoscopic biopsy.
- No invasion of the surrounding tissue.
- No distant metastasis except the liver.
Exclusion Criteria:
- Informed consent refusal
- Malignancy recurrence
- Distant metastasis except the liver.
- Locally advanced tumor.
- participants need emergent intervention e.g., intestinal obstruction or perforation.
- Contraindications specific for laparoscopy for laparoscopy cases
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: open right hemicolectomy
participants diagnosed as operable right sided colon cancer were enrolled in this study and did open combined medial and caudal resection procedure
|
resection of right colon cancer by this radical approach
|
|
Active Comparator: laparoscopic right hemicolectomy
participants diagnosed as operable right sided colon cancer were enrolled in this study and did laparoscopic combined medial and caudal resection procedure
|
resection of right colon cancer by this radical approach
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
calculate the duration of operation in both groups
Time Frame: The duration of operation was calculated intra operatively from skin incision to skin closure. it was ranging from 2 to 4 hours after skin incision.
|
The duration of operation was calculated in minutes in both groups.
group I: open combined medial and caudal right hemicolectomy and group II: laparoscopic combined medial and caudal right hemicolectomy from skin incision till skin closure intraoperatively.
|
The duration of operation was calculated intra operatively from skin incision to skin closure. it was ranging from 2 to 4 hours after skin incision.
|
|
Detection of the amount of blood loss during operation in both groups.
Time Frame: the amount of blood loss was detected intra operatively for 4 hours after skin incision.
|
the amount of blood loss during operation is calculated in cubic centimetres using scaled container connected to suction device in both groups.
|
the amount of blood loss was detected intra operatively for 4 hours after skin incision.
|
|
Detection of organ or visceral injury in both groups
Time Frame: detection of organ injury was detected intra operatively for 4 hours after skin incision.
|
detection of organ or visceral injury was done intra operatively by naked eye in both groups.
|
detection of organ injury was detected intra operatively for 4 hours after skin incision.
|
|
detection of the duration of hospital stay in both groups
Time Frame: duration of hospital stay was detected from the day of operation till the day of discharge (4 to 7 days postoperatively)
|
the duration of hospital stay was detected in days in both groups
|
duration of hospital stay was detected from the day of operation till the day of discharge (4 to 7 days postoperatively)
|
|
detection of number of resected lymph nodes in both groups
Time Frame: number of resected lymph nodes was detected from 7th to 10th day post operatively
|
the number of resected lymph nodes was detected in post operative histopathological reports in both groups.
|
number of resected lymph nodes was detected from 7th to 10th day post operatively
|
|
detection of occurrence of postoperative pain in both groups
Time Frame: detection of post operative pain in both groups was done from the day of operation to 7 days postoperatively.
|
detection of post operative pain was detected in both groups using a written scale fulfilled by the participant giving a score from 1 out of 10 points (1 to 3 points referred as minimal) (4 to 6 points referred as mild) (7 to 10 points referred as sever).
|
detection of post operative pain in both groups was done from the day of operation to 7 days postoperatively.
|
|
detection of occurrence fecal fistula in both groups
Time Frame: detection of occurrence of fecal fistula in both groups was detected from 2 to 7 days postoperatively
|
occurrence of fecal fistula in both groups was detected by vision of fecal discharge in drains from 48 hours post operatively till discharge day.
|
detection of occurrence of fecal fistula in both groups was detected from 2 to 7 days postoperatively
|
|
detection of post operative wound infection in both groups
Time Frame: post operative wound infection in both groups was detected from 2 days to one month post operatively.
|
post operative wound infection in both groups was detected by vision of wound discharge or pus.
|
post operative wound infection in both groups was detected from 2 days to one month post operatively.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Reham Z Mohamed, master, assistant lecturer of general surgery zagazig university
- Study Director: Ali H Elshewy, PhD, professor of general surgery zagazig university
- Study Chair: Abdelrahman A Sarhan, PhD, professor of general surgery zagazig university
- Study Director: Gamal M Osman, PhD, assistant professor of general surgery zagazig university
Publications and helpful links
General Publications
- Troisi RJ, Freedman AN, Devesa SS. Incidence of colorectal carcinoma in the U.S.: an update of trends by gender, race, age, subsite, and stage, 1975-1994. Cancer. 1999 Apr 15;85(8):1670-6.
- Gouvas N, Agalianos C, Papaparaskeva K, Perrakis A, Hohenberger W, Xynos E. Surgery along the embryological planes for colon cancer: a systematic review of complete mesocolic excision. Int J Colorectal Dis. 2016 Sep;31(9):1577-94. doi: 10.1007/s00384-016-2626-2. Epub 2016 Jul 28. Review.
- Jessup JM, McGinnis LS, Steele GD Jr, Menck HR, Winchester DP. The National Cancer Data Base. Report on colon cancer. Cancer. 1996 Aug 15;78(4):918-26.
- Chen Q, Shuai X, Chen L. [Safety and feasibility of the combined medial and caudal approach in laparoscopic D3 lymphadenectomy plus complete mesocolic excision for right hemicolectomy in the treatment of right hemicolon cancer complicated with incomplete ileus]. Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Sep 25;21(9):1039-1044. Chinese.
- Li F, Zhou X, Wang B, Guo L, Wang J, Wang W, Fu W. Comparison between different approaches applied in laparoscopic right hemi-colectomy: A systematic review and network meta-analysis. Int J Surg. 2017 Dec;48:74-82. doi: 10.1016/j.ijsu.2017.10.029. Epub 2017 Oct 12. Review.
- Xie D, Yu C, Gao C, Osaiweran H, Hu J, Gong J. An Optimal Approach for Laparoscopic D3 Lymphadenectomy Plus Complete Mesocolic Excision (D3+CME) for Right-Sided Colon Cancer. Ann Surg Oncol. 2017 May;24(5):1312-1313. doi: 10.1245/s10434-016-5722-1. Epub 2016 Dec 19.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- #6199-29-6-2020
- Zagazig university (Other Identifier: Zagazig university)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colon Cancer
-
Chaoxi ZhouRecruitingProximal Transverse Colon Cancer | Ascending Colon CancerChina
-
National Cancer Institute (NCI)NSABP Foundation IncCompletedColon Adenocarcinoma | Stage IIIA Colon Cancer AJCC v7 | Stage IIIB Colon Cancer AJCC v7 | Stage IIIC Colon Cancer AJCC v7 | Stage IIA Colon Cancer AJCC v7 | Stage IIB Colon Cancer AJCC v7 | Stage IIC Colon Cancer AJCC v7United States
-
Gruppo Oncologico del Nord-OvestSeagen Inc.; Servier; Foundation MedicineSuspendedStage II Colon Cancer | Stage III Colon Cancer | HER2-positive Colon Cancer | RAS Wild-type Colon CancerItaly
-
Chang Gung Memorial HospitalCompletedColon Cancer | Cancer Recurrence | Colon Adenocarcinoma | Colon Cancer Stage II | Colon Cancer Stage I | Survival Analysis | Colon Cancer Stage IIITaiwan
-
Case Comprehensive Cancer CenterCompletedStage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Stage IVA Colon Cancer | Stage IVA Rectal Cancer and other conditionsUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedFatigue | Depressive Symptoms | Stage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Psychosocial Effects of Cancer and Its Treatment | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedStage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Stage I Colon Cancer | Stage... and other conditionsUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingStage III Colon Cancer AJCC v8 | Colon Adenocarcinoma | Microsatellite Stable Colon Carcinoma | Stage IIB Colon Cancer AJCC v8 | Stage IIC Colon Cancer AJCC v8United States
-
Hospital da Senhora da OliveiraCompletedColon Cancer | Colon Adenoma | Colon Polyp | Colon Rectal CancerPortugal
-
National Cancer Institute (NCI)CompletedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Stage IVA Colon Cancer | Stage IVA Rectal Cancer | Stage IVB Colon Cancer | Stage IVB Rectal CancerUnited States
Clinical Trials on combined medial and caudal approach right hemicolectomy open and laparoscopic
-
Xu jianminCompleted
-
Zhejiang UniversityRecruitingHepatic Flexure Colon Cancer | Proximal Transverse Colon CancerChina
-
Amsterdam UMC, location VUmcProf. dr. P.J. Tanis, colorectal surgeon; Dr. B.R. Toorenvliet, colorectal... and other collaboratorsNot yet recruitingTraining | Implementation | Assessment | Consolidation | Colonic Carcinoma | Laparoscopic Right Hemicolectomy | Standardisation | Delphi StudyNetherlands
-
Corporacion Parc TauliAnna Pallisera-Lloveras; Sheila Serra-Pla; Mireia Pascua-Solé; Laura Mora-Lopez; Ricard... and other collaboratorsCompleted
-
Mansoura UniversityCompleted
-
University of Roma La SapienzaCompletedColorectal Laparoscopic ResectionItaly
-
Yonsei UniversityEnrolling by invitationAdenocarcinoma of the ColonKorea, Republic of
-
National Cancer Center, ChinaCompleted
-
Bo FengCompletedQuality of Life | Complications | Pathology | Operation Finding | Neoplasms RecurrenceChina
-
University of British ColumbiaTyco Healthcare GroupWithdrawnColon Cancer